News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioOutsource Launches Comprehensive Range of Off-the-Shelf Testing Methodologies to Support Biosimilar Characterization & Comparability Testing


9/24/2013 9:39:30 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BOSTON, Mass., US and GLASGOW, Scotland, UK, September 23, 2013 / B3C newswire / – BioOutsource Ltd. (“BioOutsource”), a leading international Contract Testing Organization (CTO) has consolidated its position as the leading expert in the biological analysis of Biosimilar Monoclonal Antibodies for the biopharmaceutical industry. Strategic internal R&D investment has enabled the creation and launch of a wide range of off-the-shelf testing methodologies to support comparability, stability and lot release testing for Biosimilars. As a result the company has achieved excellent market penetration and sales growth this year and is now working in collaboration with many of the world’s leading Biosimilar companies.

“Our extensive experience in developing and validating cell-based assays and strategic R&D investment has created a niche position for us within the industry, which enables BioOutsource to provide testing solutions that can significantly reduce the time and cost of Biosimilar development programmes,” commented BioOutsource CEO Gerry MacKay. “We are continuing to invest and expand our testing capabilities in Glasgow, Scotland and are significantly increasing commercial activities in the North American and Asia-Pacific regions to support surging demand for Biosimilar characterisation & comparability testing. We are delighted to be working with more than 30 of the top Biosimilar players globally, and look forward to continued strong growth in 2014.”

About BioOutsource Ltd

BioOutsource provides contract testing services to the biopharmaceutical industry. Our core offering includes a comprehensive range of services to support the testing of Biologics, Vaccines & Biosimilars throughout their development. We possess an unparalleled combination of commercial, regulatory and technical knowledge that enables us to truly stand out as the industry’s increasingly preferred testing partner. We understand the importance of our service to support our client’s critical testing requirements and as a result, continually strive to provide a world class service globally.

Contacts:

Dr. Verna McErlane

Director of Sales

BioOutsource, Ltd.

+ 44 (0) 141 946 4222

VMcErlane@biooutsource.com

or

Bill Douglass

Gotham Communications, LLC

1-646-504-0890

bill@gothamcomm.com

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES